Cargando…

Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis

AIMS: Chronic pressure overload and right ventricular (RV) dysfunction can lead to RV–pulmonary artery (PA) uncoupling in patients with heart failure. The evolution and prognostic values of RV–PA coupling assessed by echocardiography in patients undergoing cardiac resynchronization therapy (CRT) hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Stassen, Jan, Galloo, Xavier, Hirasawa, Kensuke, Chimed, Surenjav, Marsan, Nina Ajmone, Delgado, Victoria, van der Bijl, Pieter, Bax, Jeroen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065855/
https://www.ncbi.nlm.nih.gov/pubmed/35266319
http://dx.doi.org/10.1002/ehf2.13857
_version_ 1784699680482918400
author Stassen, Jan
Galloo, Xavier
Hirasawa, Kensuke
Chimed, Surenjav
Marsan, Nina Ajmone
Delgado, Victoria
van der Bijl, Pieter
Bax, Jeroen J.
author_facet Stassen, Jan
Galloo, Xavier
Hirasawa, Kensuke
Chimed, Surenjav
Marsan, Nina Ajmone
Delgado, Victoria
van der Bijl, Pieter
Bax, Jeroen J.
author_sort Stassen, Jan
collection PubMed
description AIMS: Chronic pressure overload and right ventricular (RV) dysfunction can lead to RV–pulmonary artery (PA) uncoupling in patients with heart failure. The evolution and prognostic values of RV–PA coupling assessed by echocardiography in patients undergoing cardiac resynchronization therapy (CRT) have not been thoroughly investigated. The aim of this study was to evaluate the evolution and prognostic value of tricuspid annular plane systolic excursion (TAPSE)/pulmonary artery systolic pressure (PASP) ratio in CRT recipients. METHODS AND RESULTS: The RV–PA coupling was measured non‐invasively with echocardiography using the TAPSE/PASP ratio at baseline and 6 month follow‐up in CRT recipients. The cut‐off value for TAPSE/PASP uncoupling was derived from spline curve analysis (i.e. <0.45 mm/mmHg). The primary endpoint was all‐cause mortality. A total of 807 patients (age 66 ± 11 years, 76% men) were analysed. During a median follow‐up of 97 (54–143) months, 483 (60%) patients died. Survival rates at 3 and 5 year follow‐up were significantly lower for patients with a TAPSE/PASP ratio <0.45 mm/mmHg (76% and 58%, respectively), compared with those with a TAPSE/PASP ratio ≥0.45 mm/mmHg (91% and 82%, respectively) (P < 0.001). On multivariable analysis, TAPSE/PASP ratio <0.45 mm/mmHg (hazard ratio 1.437; 95% confidence interval: 1.145–1.805; P = 0.002) was independently associated with all‐cause mortality, whereas TAPSE <17 mm (hazard ratio 1.237; 95% confidence interval: 0.990–1.546; P = 0.061) was not. In addition, no improvement of the TAPSE/PASP ratio after CRT implantation was independently associated with worse survival. CONCLUSIONS: The TAPSE/PASP ratio at baseline is independently associated with long‐term outcomes in CRT recipients. The baseline TAPSE/PASP ratio has incremental value over TAPSE, which does not take account of RV afterload. A lack of improvement in the TAPSE/PASP ratio after CRT implantation is associated with worse survival.
format Online
Article
Text
id pubmed-9065855
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90658552022-05-04 Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis Stassen, Jan Galloo, Xavier Hirasawa, Kensuke Chimed, Surenjav Marsan, Nina Ajmone Delgado, Victoria van der Bijl, Pieter Bax, Jeroen J. ESC Heart Fail Original Articles AIMS: Chronic pressure overload and right ventricular (RV) dysfunction can lead to RV–pulmonary artery (PA) uncoupling in patients with heart failure. The evolution and prognostic values of RV–PA coupling assessed by echocardiography in patients undergoing cardiac resynchronization therapy (CRT) have not been thoroughly investigated. The aim of this study was to evaluate the evolution and prognostic value of tricuspid annular plane systolic excursion (TAPSE)/pulmonary artery systolic pressure (PASP) ratio in CRT recipients. METHODS AND RESULTS: The RV–PA coupling was measured non‐invasively with echocardiography using the TAPSE/PASP ratio at baseline and 6 month follow‐up in CRT recipients. The cut‐off value for TAPSE/PASP uncoupling was derived from spline curve analysis (i.e. <0.45 mm/mmHg). The primary endpoint was all‐cause mortality. A total of 807 patients (age 66 ± 11 years, 76% men) were analysed. During a median follow‐up of 97 (54–143) months, 483 (60%) patients died. Survival rates at 3 and 5 year follow‐up were significantly lower for patients with a TAPSE/PASP ratio <0.45 mm/mmHg (76% and 58%, respectively), compared with those with a TAPSE/PASP ratio ≥0.45 mm/mmHg (91% and 82%, respectively) (P < 0.001). On multivariable analysis, TAPSE/PASP ratio <0.45 mm/mmHg (hazard ratio 1.437; 95% confidence interval: 1.145–1.805; P = 0.002) was independently associated with all‐cause mortality, whereas TAPSE <17 mm (hazard ratio 1.237; 95% confidence interval: 0.990–1.546; P = 0.061) was not. In addition, no improvement of the TAPSE/PASP ratio after CRT implantation was independently associated with worse survival. CONCLUSIONS: The TAPSE/PASP ratio at baseline is independently associated with long‐term outcomes in CRT recipients. The baseline TAPSE/PASP ratio has incremental value over TAPSE, which does not take account of RV afterload. A lack of improvement in the TAPSE/PASP ratio after CRT implantation is associated with worse survival. John Wiley and Sons Inc. 2022-03-09 /pmc/articles/PMC9065855/ /pubmed/35266319 http://dx.doi.org/10.1002/ehf2.13857 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Stassen, Jan
Galloo, Xavier
Hirasawa, Kensuke
Chimed, Surenjav
Marsan, Nina Ajmone
Delgado, Victoria
van der Bijl, Pieter
Bax, Jeroen J.
Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis
title Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis
title_full Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis
title_fullStr Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis
title_full_unstemmed Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis
title_short Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis
title_sort right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065855/
https://www.ncbi.nlm.nih.gov/pubmed/35266319
http://dx.doi.org/10.1002/ehf2.13857
work_keys_str_mv AT stassenjan rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis
AT gallooxavier rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis
AT hirasawakensuke rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis
AT chimedsurenjav rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis
AT marsanninaajmone rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis
AT delgadovictoria rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis
AT vanderbijlpieter rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis
AT baxjeroenj rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis